The Global Alzheimer’s Platform Foundation® (GAP) today issued a statement following the release of top-line updates from two Alzheimer’s clinical trials: Recently, developments in two important Alzheimer’s clinical research studies were reported. The two studies were: Novo Nordisk’s Phase 3 EVOKE and EVOKE+ trials evaluating oral semaglutide, and Johnson & Johnson’s Phase 2b trial evaluating the […]
About This Episode The quest to speed up clinical trials is personal for John Dwyer, CEO of the Global Alzheimer’s Platform (GAP). A long-time UsA2 advocate, he’s been motivated by the generations of family members lost to Alzheimer’s and Parkinson’s disease. Dwyer shares with BrainStorm host Meryl Comer the critical challenges of NIH funding cuts […]
November 19, 2025 Delivers Life-Changing Early Detection for 580,000 Floridians Living with Alzheimer’s WASHINGTON — Today, Congressman Vern Buchanan, Vice Chairman of the House Ways and Means Committee and Chair of the Health Subcommittee, announced the introduction of the Alzheimer’s Screening and Prevention (ASAP) Act alongside Congressman Paul Tonko (D-N.Y.). Senators Susan Collins (R-Maine) and Catherine Cortez Masto (D-Nev.) introduced companion legislation in the Senate. This bipartisan, bicameral […]
Last week, the Global Alzheimer’s Platform Foundation’s (GAP) Inclusive Research Initiative (IRI) team hosted its second annual virtual conference focused on improving Alzheimer’s and dementia research by increasing diversity among participants in neurodegenerative clinical trials. We are proud to have created a platform for meaningful dialogue and hope it has inspired new ideas, collaborations, and opportunities for those […]
IMPERIAL COUNTY, Calif. (KYMA) – The Sun Valley Research Center (SVRC) is taking a Mobile Research Unit on the road to hold free memory assessments. According to a press release, THOR (Taking Health on the Road) West is touring California and Arizona in order to help raise awareness of the importance of brain health.According to […]
How the U.S. can drive progress into the next era of Alzheimer’s disease careSponsored by Lilly Today, over 7 million Americans are living with Alzheimer’s disease — a number that is expected to more than double by 2060, according to the Alzheimer’s Association. The stakes for the U.S. health care system have never been higher. A […]
International non-profit Global Alzheimer’s Platform Foundation expands research network in California to improve access to research opportunities Washington D.C.- Global Alzheimer’s Platform Foundation® (GAP) announced in a recent press release the addition of Sun Valley Research Center (SVRC) a private clinical research organization based in Imperial, California, to its global network of over 100 best-in-class research sites. SVRC addresses the critical […]
International non-profit Global Alzheimer’s Platform Foundation expands research network in California to improve access to research opportunities Washington D.C., Oct. 14, 2025- Global Alzheimer’s Platform Foundation® (GAP) announces the addition of Sun Valley Research Center (SVRC) a private clinical research organization based in Imperial, California, to its global network of over 100 best-in-class research sites. SVRC […]
Posted on October 2, 2025 • by Julia Ferrar Most biomarker tests, such as PET scans and spinal taps, are expensive or invasive and can pose risks for patients. That’s why a company in the Tampa Bay area is helping to research blood tests for biomarkers as a less expensive and more accessible alternative. Axiom […]
FOX 13’s Allie Corey and her guest discuss Alzheimer’s and the latest research in the disease. Watch the interview with Dr. Steen of Axiom Brain Health here: https://www.fox13news.com/video/1715786
Prevent cognitive decline with these proven lifestyle changes! Join us on PSI TV as Dr. Susan Steen, MD, a renowned neurologist and Alzheimer’s expert, shares groundbreaking insights into brain health. Representing Axiom Brain Health, Dr. Steen discusses their mission to combat neurodegenerative diseases like Alzheimer’s and Parkinson’s through cutting-edge research and clinical trials. Learn how […]
Researchers at Emory Goizueta Brain Health Institute and partner institutions have found new clues in the blood that could help explain why Alzheimer’s disease develops and how it affects memory. The study, published in Nature Aging, examined blood samples from more than 2,100 individuals across four large research cohorts. Using advanced tools, scientists measured thousands of proteins in […]
Strategic collaborations are key to improving the pace and access to research. Undiagnosed and Overlooked Everyone knows someone impacted by Alzheimer’s disease, as it affects an estimated 55 million people worldwide. What is often overlooked is the shocking number of people who remain undiagnosed due to fear of going to a doctor, lack of access […]
Story by Ronna Charles • 2 min read Researchers at Emory Goizueta Brain Health Institute and partner institutions have found new clues in the blood that could help explain why Alzheimer’s disease develops and how it affects memory.The study, published in Nature Aging, examined blood samples from more than 2,100 individuals across four large research cohorts. […]
trialsitenews, Aug. 28, 2025, 12:30 p.m. September is Alzheimer’s Awareness Month, a time to reflect on the devastating impact of Alzheimer’s disease and the urgent need for better treatments and care. More than 6 million Americans are living with Alzheimer’s, a number expected to climb steeply in the coming decades. As the need grows, so […]
22 Aug 2025 The current Alzheimer’s disease therapeutic antibodies carry a sizable risk of ARIA, especially for APOE4 carriers. Researchers believe the future of amyloid immunotherapies lies in targeted brain delivery that bypasses the larger blood vessels prone to this side effect, and several companies are working on this. At the Alzheimer’s Association International Conference, […]
A groundbreaking mobile research unit made its West Coast debut in Mission Viejo on Saturday, August 9, at Mount of Olives Church. The Healthy Brain Clinic launched the unit to improve access to brain health education and services. With 12% of Californians currently living with Alzheimer’s disease, the mobile unit aims to lower barriers for […]
Axiom Brain Health recently launched a new Florida-based mobile research unit that will tour the state to improve accessibility to brain health education and services in Tampa. A ribbon cutting was held Aug. 6 at the New Mt. Zion Baptist Church in Tampa featuring Pastor Larry Roundtree, the experts from Axiom Brain Health, and The […]
Mission Viejo, Aug 12, 2025— Brain health is being taken on the road in Mission Viejo with a Mobile Research Unit that will tour the West Coast to improve accessibility to brain health education and services. The Mobile Research Unit made its debut on August 9 with a ribbon cutting with The Healthy Brain Clinic […]
Florida Mobile Research Unit Launched with Axiom Brain Health at New Mt. Zion Baptist Church Tampa, FL Aug 6, 2025— Brain health is being taken on the road in Tampa as Axiom Brain Health launched a new Florida-based mobile research unit that will tour the state, to improve accessibility to brain health education and […]
The Global Alzheimer’s Platform Foundation (GAP) and the Alzheimer’s Disease Data Initiative (AD Data Initiative) have released the Bio?Hermes?001 dataset — described as the most comprehensive biomarker dataset in Alzheimer’s research history. The release of Bio?Hermes?001 marks a pivotal moment in Alzheimer’s research: a first?of?its?kind dataset blending biomarker, cognitive, retinal, and speech data across a deeply diverse cohort. Now available to scientists worldwide, […]
Data from Most Deeply Characterized Cohort Across Alzheimer’s Disease Released byGlobal Alzheimer’s Platform Foundation and Alzheimer’s Disease Data Initiative Washington D.C., July 31, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) and the Alzheimer’s Disease Data Initiative (AD Data Initiative) announced today that data generated from the Bio-Hermes-001 study are now publicly available. This release […]
OliverBlake, Sunday, Jul 27, 2025 4:21 pm ETThe global Alzheimer’s disease market is a high-stakes arena where innovation and precision collide. With over 60 million people affected worldwide and a projected $19.44 billion market size by 2030, the race to develop disease-modifying therapies (DMTs) and diagnostics is intensifying. Roche, a pharmaceutical giant with a legacy […]
Washington, DC -July 28, 2025 –The Global Alzheimer’s Platform Foundation® (GAP), an international leader in accelerating clinical trials and improving recruitment, announced a collaboration with Genentech, a member of the Roche Group, to expand access to clinical trials for communities underrepresented in Alzheimer’s research. This partnership will leverage the combined expertise of GAP’s Site Alliance […]